Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-03-27

FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Desmopressin Acetate submitted by Meitheal Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desmopressin Acetate (Desmopressin acetate)

Snippet

SUPPL AP for DESMOPRESSIN ACETATE (DESMOPRESSIN ACETATE)